These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9109740)

  • 1. Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases.
    Wessel K; Langenberger K; Nitschke MF; Kömpf D
    Arch Neurol; 1997 Apr; 54(4):397-400. PubMed ID: 9109740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases.
    Wessel K; Hermsdörfer J; Deger K; Herzog T; Huss GP; Kömpf D; Mai N; Schimrigk K; Wittkämper A; Ziegler W
    Arch Neurol; 1995 May; 52(5):451-5. PubMed ID: 7733838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physostigmine in treatment of cerebellar ataxia].
    Aschoff JC; Kailer NA; Walter K
    Nervenarzt; 1996 Apr; 67(4):311-8. PubMed ID: 8684510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia.
    Sorbi S; Forleo P; Fani C; Piacentini S
    Clin Neuropharmacol; 2000; 23(2):114-8. PubMed ID: 10803803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid as a reflector of central cholinergic and amino acid neurotransmitter activity in cerebellar ataxia.
    Manyam BV; Giacobini E; Ferraro TN; Hare TA
    Arch Neurol; 1990 Nov; 47(11):1194-9. PubMed ID: 1978660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physostigmine in familial ataxias.
    Kark RA; Blass JP; Spence MA
    Neurology; 1977 Jan; 27(1):70-2. PubMed ID: 556821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatments of cerebellar ataxia.
    Ogawa M
    Cerebellum; 2004; 3(2):107-11. PubMed ID: 15233578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Acetyl-DL-Leucine in Certain Types of Cerebellar Ataxia: The ALCAT Randomized Clinical Crossover Trial.
    Feil K; Adrion C; Boesch S; Doss S; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Steiner KM; Stendel C; Timmann D; Naumann I; Mansmann U; Strupp M;
    JAMA Netw Open; 2021 Dec; 4(12):e2135841. PubMed ID: 34905009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    Feil K; Adrion C; Teufel J; Bösch S; Claassen J; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Stendel C; Uslar E; van de Warrenburg B; Berger I; Naumann I; Bayer O; Müller HH; Mansmann U; Strupp M
    BMC Neurol; 2017 Jan; 17(1):7. PubMed ID: 28068987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral choline in cerebellar ataxia.
    Sehested P; Lund HI; Kristensen O
    Acta Neurol Scand; 1980 Aug; 62(2):124-6. PubMed ID: 7211160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy.
    Trouillas P; Xie J; Adeleine P; Michel D; Vighetto A; Honnorat J; Dumas R; Nighoghossian N; Laurent B
    Arch Neurol; 1997 Jun; 54(6):749-52. PubMed ID: 9193210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of physostigmine on visual-vestibular interaction in hereditary ataxias.
    Tijssen CC; Endtz LJ; Goor C
    J Neurol Neurosurg Psychiatry; 1985 Oct; 48(10):977-81. PubMed ID: 3877148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing.
    Trouillas P; Brudon F; Adeleine P
    Arch Neurol; 1988 Nov; 45(11):1217-22. PubMed ID: 3190503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group.
    van Dyck CH; Newhouse P; Falk WE; Mattes JA
    Arch Gen Psychiatry; 2000 Feb; 57(2):157-64. PubMed ID: 10665618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of physostigmine on inherited ataxias.
    Rodriguez-Budelli MM; Kark RA; Blass JP; Spence MA
    Adv Neurol; 1978; 21():195-202. PubMed ID: 735925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, triple-crossover trial of low doses of oral physostigmine in inherited ataxias.
    Kark RA; Budelli MM; Wachsner R
    Neurology; 1981 Mar; 31(3):288-92. PubMed ID: 7010207
    [No Abstract]   [Full Text] [Related]  

  • 17. The cholinesterase inhibitor physostigmine for the local treatment of dry mouth: a randomized study.
    Khosravani N; Birkhed D; Ekström J
    Eur J Oral Sci; 2009 Jun; 117(3):209-17. PubMed ID: 19583746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M
    Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.
    Thal LJ; Schwartz G; Sano M; Weiner M; Knopman D; Harrell L; Bodenheimer S; Rossor M; Philpot M; Schor J; Goldberg A
    Neurology; 1996 Dec; 47(6):1389-95. PubMed ID: 8960716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choline chloride in the treatment of cerebellar and spinocerebellar ataxia.
    Livingstone IR; Mastaglia FL; Pennington RJ; Skilbeck C
    J Neurol Sci; 1981 May; 50(2):161-74. PubMed ID: 7229661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.